Stanford continues to be at the forefront of healthcare innovation and at their annual event "Frontiers in Medicine" they explored medicine’s hottest topic—artificial intelligence—and its potential to transform human health. With our roots in Stanford University School of Medicine, its no surprise that they continue to encourage the development of innovative technologies that improve patient care and personalize treatment choices. As the pace of innovation in medicine grows, the responsible use of AI is more important than ever, especially when applied to research and patient care. Our favorite part starts at 59:12, with a mention of #AtroposHealth. Frontiers in Medicine 2024: AI in Bloom https://hubs.li/Q02RBCdW0 #Healthtech #AI #AIinhealthcare #HealthcareAI
Atropos Health
Hospitals and Health Care
Palo Alto, CA 6,609 followers
The future of evidence-based medicine.
About us
Atropos Health is the developer of the first physician consultation service powered by publication-grade real-world evidence. Using millions of anonymized patient records, we help providers answer clinical questions that have fallen through the cracks of the evidence-based literature. The company spun out of the School of Medicine at Stanford University in 2020 after a successful multi-year pilot that generated new evidence across 18 clinical specialties.
- Website
-
http://www.atroposhealth.com
External link for Atropos Health
- Industry
- Hospitals and Health Care
- Company size
- 11-50 employees
- Headquarters
- Palo Alto, CA
- Type
- Privately Held
- Founded
- 2020
- Specialties
- real world Data, Second opinion, Evidence based medicine, ai, and healthcare
Locations
-
Primary
Palo Alto, CA 94304, US
Employees at Atropos Health
Updates
-
In his September 19 report, Giles Bruce at Becker's Healthcare covered the top 10 venture capital deals from Q2024 in health IT. The #AtroposHealth $33M Series B funding in May made the list: https://hubs.li/Q02RBF020 #healthIT #healthcareIT
-
Hear more about how Artificial Intelligence (AI) can bridge the evidence gap in healthcare in this interview with #AtroposHealth CEO and co-Founder Dr. Brigham Hyde and ⬥ Ardy Arianpour ⬥ CEO of SEQSTER hosted by DR. CINDY GORDON ICD.D.. #HealthcareInnovation #AI #DataDemocratization #HealthcareAI #AIinHealthcare #RealWorldEvidence #RWE
Bridging the Healthcare Evidence Gap with AI! I had the pleasure of interviewing two visionary CEOs, Dr. Brigham Hyde of Atropos Health and ⬥ Ardy Arianpour ⬥ of SEQSTER, on the SalesChoice Inc. Predictive World podcast. Their bold vision is to democratize healthcare data and tackle the fragmented healthcare market—an effort that’s transforming patient care and empowering healthcare professionals. Check out the full podcast for an in-depth discussion on their innovative approaches and the future of healthcare!
Transforming Healthcare Leveraging Innovative Data Approaches
DR. CINDY GORDON ICD.D. on LinkedIn
-
Check out the latest updates to the Atropos Evidence™ Network, the largest federated healthcare data network with 300M patient records. Membership benefits now include Data Quality ScoreCards and access to advanced AI tools to generate real-world evidence (RWE). The data quality scores are based on transparent and objective criteria. In addition to the score, the Data Quality ScoreCard also includes confidential and transparent feedback on how to improve the data quality. As the importance of data quality continues to rise, the ability to objectively measure the value of the investments data holders have made is critical, according to CEO and co-Founder of Atropos Health Dr. Brigham Hyde. By providing suggestions for data enrichment, data holders can grow and highlight their value to a variety of use cases for data users. The Atropos Evidence Network is for Clinicians and Researchers (those seeking evidence-based medicine insights), Data Providers & Partners (RWD source holders) and Technology Solution Partners (builders who want to advance healthcare). Joining the Atropos Evidence Network is easy. Membership packages, designated Silver, Gold, and Platinum are designed to meet members needs for data and tools. New members will join an already impressive slate of leaders in the healthcare ecosystem include Forian Inc., Syndesis Health, and Norstella. Read more on our press release: https://hubs.li/Q02QCpVZ0 #HealthcareInnovation #DataQuality #AI #AtroposHealth #RWD #RealWorldData #RWE #RealWorldEvidence #HealthcareAI #AIinHealthcare
Atropos Health Announces Data Quality ScoreCard and AI Tools as New Benefits to All Atropos Evidence Network Members
businesswire.com
-
Most industries, including pharma, are harnessing the power of generative AI. The technology holds the promise to predict drug-target interactions, optimize lead compounds and generate novel molecular structures more rapidly than ever before. Hear how Atropos Health CEO and co-founder Dr. Brigham Hyde answers the question, "How is Pharma Leveraging AI?" with fellow panelists Naomi Fried, Ph.D. from PharmStars and Dave Latshaw II, PhD, MBA from BioPhy hosted by Katie Adams from MedCity News as they discuss how the pharma industry is deploying generative AI to drive better research and accelerate drug discovery. Join other healthcare futurists, payers, providers, investors and entrepreneurs who seek to transform digital health as they gather to discuss healthcare AI at Medcity Invest. Read more about how Atropos Health's generative AI solution, ChatRWD™ outperformed other LLMs: https://hubs.li/Q02QfkqR0 #GenerativeAI #PharmaInnovation #DrugDiscovery #HealthcareAI #AtroposHealth #AIinhealthcare
-
We kicked off September by meeting with our Clinical Advisory Board (CAB) and Life Sciences (LS) Advisory Board teams. This virtual, combination meeting provided an opportunity for updates and feedback headed into September. Agenda items included ChatRWD™ the first generative AI application to deliver full observational studies on healthcare data in minutes, the Atropos Evidence™ Network, the largest federated healthcare data network and Alexandria™, the Atropos Evidence™ Library. Thank you to all of our advisors for your time and commitment to our mission to accelerate the generation of actionable evidence to improve healthcare outcomes for everyone. Nick Patel M.D., David Klonoff, Elmer Polite, Rasu Shrestha MD MBA, Tim Suther, Brian Hasselfeld, MD, Joseph Scalea, MD, David McSwain, MD MPH, Neera Ahuja, Robert A. Harrington, Tip Kim, Gerry McDougall, Gabriel Eichler, Sean Khozin, and Barbara Salami More information about our CAB here: https://hubs.li/Q02Q6g2Q0 #AtroposHealth #ChatRWD #AIinHealthcare #RealworldEvidence #RWE #InnovationInMedicine #PatientCare #LargeLanguageModels #LLM #RWD #Realworlddata
-
Save the date! October 3, 2024 at One Tower Place in South San Francisco - hear #AtroposHealth Chief Medical Officer and co-founder Dr. Saurabh Gombar's expert perspective on how AI is driving the discovery, development and delivery of innovative medicines today.
🚀 California Life Sciences (CLS) is thrilled to announce our speaker roster, for the upcoming, West Coast AI Summit: The Transformative Power of AI in Pharmaceutical R&D! Hear from our esteemed panelists who will dive into the latest AI advancements, including drug discovery, personalized medicine, and patient care transformation: Stacy Feld, Regional Head, Johnson & Johnson Innovation West North America Tina Hernandez-Boussard, PhD MPH, Associate Dean of Research and Professor of Medicine (Biomedical Informatics), Biomedical Data Sciences, Surgery and Epidemiology & Population Health (by courtesy), Stanford University Hilary Eaton, PhD, Chief Business Officer, Profluent Jim Martineau, MBA, Co-Founder & CEO, Nosis Bio (moderator) Justin Scheer, PhD, Vice President, In Silico Discovery, Johnson & Johnson Innovative Medicine e Saurabh Gombar, MD PhD, Chief Medical Officer & Co-Founder, Atropos Health Tripthi Kamath, PhD, Vice President, Immunology, R&D Data Science & Digital Health, Innovative Medicine, Johnson & Johnson Deepa Lalla, PhD, Vice President, Evidence Generation, Publications and Partnerships, AstraZeneca Mark Lee, MD PhD, Chief Executive Officer & Co-Founder, N-Power Medicine, Inc. Medicines (moderator) Anita Modi, MBA, Chief Executive Officer & Co-Founder, Peer AI Christopher A. Haskell, PhD, Head, JLABS San Francisco Bay Area, Johnson & Johnson Vasudev Bailey, PhD, Managing Partner, ARTIS Ventures Ekaterine (Eka) Kortkhonjia, PhD, Senior Director, Early Innovation Partnering, Johnson & Johnson (moderator) Lynne Chou O'Keefe’Keefe, MBA, Founder & Managing Partner, Define Ventures Qing Z. Zhang, MD MBA, Partner, LDV Partners Join and connect with top innovators and decision-makers driving the future of AI and life sciences! Register Now: https://bit.ly/3AR7Ib1:
West Coast Summit: The Transformative Power of AI in Pharmaceutical R&D - California Life Sciences
https://www.califesciences.org
-
Coming to Boston for LSX World Congress? Meet with our team to learn more about #RealWorldEvidence for healthcare.
I'll be at the LSX World Congress USA, taking place on September 11, 2024. If you're also going, let's connect! #LSXWorld https://lnkd.in/ddrwaMDg LSX USA Congress
-
Great series by MobiHealthNews
Thank you to everyone who contributed to MobiHealthNews' Investment Series! Your expertise and diverse perspectives were invaluable in shaping the conversation around digital health investments and partnerships. I’m grateful for the knowledge shared by: ▪ Daisy Wolf, Investing Partner at Andreessen Horowitz (a16z Bio Health) ▪ Matt Cybulsky, PhD, Practice Leader for Healthcare AI at LBMC ▪ Sonny Shergill, VP of Commercial Digital Health at AstraZeneca ▪ Brigham Hyde, CEO of Atropos Health ▪ Daniel O'Brien, President for the Americas at HTC VIVE ▪ Justin Barad, MD, Founder of Osso VR ▪ Holly Maloney, Managing Director at General Catalyst ▪ Ben Robbins, General Partner at GV (Google Ventures) Your input provided beneficial insights into the various viewpoints on digital health funding and the progress of healthcare innovation. It was thought-provoking to explore the perspectives of pharma, venture funds, consulting, emerging technologies, and vendors on the topic. Check out all the above interviews on MobiHealthNews' dedicated page for the series! #DigitalHealth #HealthTech #Investment #Innovation #MobiHealthNews #a16z #LBMC #AstraZeneca #AtroposHealth #HTCVive #OssoVR #GeneralCatalyst #Google #GoogleVentures HIMSS Media HIMSS #digitalhealthfunding #digitalhealthinvestment #investmentseries
Investment Series
mobihealthnews.com
-
Are prophylactic antibiotics necessary before thyroid surgery? A recent study by Atropos Health Chief Medical Officer and co-founder Dr. Saurabh Gombar examined the association between antibiotic prophylaxis and surgical site infections (SSI) in patients undergoing thyroidectomy. With the potential risks of antibiotic resistance and adverse reactions, it's important to reevaluate the need for prophylactic antibiotics in thyroid surgery. Using Real World Evidence can result in better patient outcomes. Thanks to co-authors Samuel Squires, MMCi, Robin M. Cisco MD, Dana T. Lin MD, Amber W. Trickey PhD, MS, CPH, Electron Kebebew MD, Ye Yuan MD, PhD, and Carolyn D. Seib MD, MAS for your collaboration. Read the conclusions here: https://hubs.li/Q02MnHkc0 and in the Journal of Surgical Research. #ThyroidSurgery #SurgicalSiteInfections #PatientSafety #EvidenceBasedMedicine #AtroposHealth #RWE #Realworldevidence #antibioticResistance
Benefits and Risks Associated With Antibiotic Prophylaxis for Thyroid Operations — Atropos Health
atroposhealth.com